Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Gottlieb Announces Revised MOU on Distribution of Compounded Drugs

  • Post author:Sam
  • Post published:October 10, 2018
  • Post category:International Pharmaceutical Regulatory Monitor

FDA Commissioner Scott Gottlieb announced a revised agreement between the agency and states on interstate distribution of compounded drugs, responding to concerns that the existing distribution limits are too low.…

Continue ReadingGottlieb Announces Revised MOU on Distribution of Compounded Drugs

Devicemakers Critical of FDA Test Methods for Metal Biliary Stent PMAs

  • Post author:Sam
  • Post published:October 4, 2018
  • Post category:The GMP Letter

Boston Scientific and Cook Medical questioned parts of the FDA’s guidance on premarket notifications for metal expandable biliary stents and their delivery systems — including limits on eligibility for the…

Continue ReadingDevicemakers Critical of FDA Test Methods for Metal Biliary Stent PMAs

483 Roundup: FDA Cites Six Firms for Quality, GMP Violations

  • Post author:Sam
  • Post published:October 4, 2018
  • Post category:The GMP Letter

The FDA flagged six devicemakers for a variety of deficiencies including complaint handling, inadequate documentation and quality system failures. Source: The GMP Letter

Continue Reading483 Roundup: FDA Cites Six Firms for Quality, GMP Violations

FDA Warns Devicemakers Over Pen Needles

  • Post author:Sam
  • Post published:October 4, 2018
  • Post category:The GMP Letter

CDRH issued a Sept. 27 memo to alert device manufacturers about a post-market safety issue concerning pen needles used with pen injectors. Source: The GMP Letter

Continue ReadingFDA Warns Devicemakers Over Pen Needles

FDA Proposed Rule Would Simplify Premarket Device Submissions

  • Post author:Sam
  • Post published:October 4, 2018
  • Post category:The GMP Letter

The FDA released a proposed rule that would simplify the process for electronic premarket device submissions. Source: The GMP Letter

Continue ReadingFDA Proposed Rule Would Simplify Premarket Device Submissions

FDA Warns ITG-Medev for Validations, Other Failures

  • Post author:Sam
  • Post published:October 4, 2018
  • Post category:The GMP Letter

ITG-Medev failed to follow up on its promised solutions to nonconforming process validations and documentation of acceptance activities, the FDA said in a warning letter to the devicemaker. Source: The…

Continue ReadingFDA Warns ITG-Medev for Validations, Other Failures

FDA Says Medtronic Facilities Must Undergo Followup Inspections

  • Post author:Sam
  • Post published:October 4, 2018
  • Post category:The GMP Letter

The FDA hit two Medtronic device facilities with warning letters last week, citing faulty device history records and CAPA procedures. Source: The GMP Letter

Continue ReadingFDA Says Medtronic Facilities Must Undergo Followup Inspections

FDA Gives Feedback to Congress on New Diagnostics Standards

  • Post author:Sam
  • Post published:October 4, 2018
  • Post category:The GMP Letter

FDA Commissioner Scott Gottlieb said the agency has advised Congress to take a three-pronged approach to modernizing diagnostics standards. Source: The GMP Letter

Continue ReadingFDA Gives Feedback to Congress on New Diagnostics Standards

OIG: FDA Needs to Better Integrate Cybersecurity Into Device Reviews

  • Post author:Sam
  • Post published:October 4, 2018
  • Post category:The GMP Letter

The FDA needs to do more to ensure the cybersecurity of networked medical devices, according to a new report from the HHS Office of Inspector General. Source: The GMP Letter

Continue ReadingOIG: FDA Needs to Better Integrate Cybersecurity Into Device Reviews

FDA May Remove New Drug Approval Step for Irradiated OTC Drugs

  • Post author:Sam
  • Post published:October 2, 2018
  • Post category:Drug GMP Report

The FDA proposed a rule to allow OTC drugs sterilized by irradiation to be marketed legally without an agency-approved NDA or ANDA. Source: Drug GMP Report

Continue ReadingFDA May Remove New Drug Approval Step for Irradiated OTC Drugs
  • Go to the previous page
  • 1
  • …
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.